Key result
Immune-fibroblast ligand-receptor signaling drives post-MI cardiac fibrosis via pathways conserved with cancer-associated fibroblasts.
Why the study?
Post-infarction cardiac fibrosis is a principal contributor to heart failure driven by ligand-receptor-mediated crosstalk between immune cells and cardiac fibroblasts, with many interactions conserved in cancer-associated fibroblast biology. This review consolidates recent multi-omic findings on these signaling axes and their therapeutic prospects across cardiac and neoplastic diseases.
Answers are grounded in this paper and cite their sources.
This mini-review synthesizes multi-omic findings on immune-fibroblast ligand-receptor crosstalk during post-myocardial infarction cardiac remodeling, highlighting conserved signaling pathways shared with cancer-associated fibroblasts that offer potential targets for antifibrotic therapies.
Myocardial infarction-triggered cardiac fibrosis is a cardinal feature of maladaptive ventricular remodeling and a principal contributor to heart failure pathogenesis. Enabled by single-cell RNA sequencing and spatial transcriptomics, accumulating evidence demonstrates that post-infarction fibrosis represents an actively coordinated biological program rather than a passive wound-healing event, which is governed by ligand-receptor-mediated crosstalk between immune cells and cardiac fibroblasts. Pioneering work has established monocyte-derived macrophages as a predominant cellular source of pro-inflammatory interleukin-1β; upon binding its cognate receptor on fibroblasts, this cytokine instigates the generation of pro-fibrotic fibroblast subsets within spatially segregated niches of the infarcted myocardium. Multiple additional ligand-receptor modules, encompassing osteopontin-CD44/integrin, transforming growth factor-β, platelet-derived growth factor, as well as growth arrest-specific protein 6-MER tyrosine kinase, further fine-tune fibroblast activation trajectories in a spatiotemporally-restricted fashion. Intriguingly, a substantial fraction of these ligand-receptor interactions are conserved in cancer-associated fibroblast biology, wherein osteopontin-producing macrophages and activated fibroblasts collaboratively build pro-tumor stromal microenvironments. We consolidate recent multi-omic findings regarding immune-fibroblast ligand-receptor communication during post-infarction cardiac remodeling, highlight mechanistic analogies to cancer-associated fibroblast activation, and discuss therapeutic prospects arising from targeting these conserved signaling nodes across cardiac and neoplastic diseases.
No takes yet. Share an insight, caveat, or question.
陆红 et al. (2026) conducted a review in Post-infarction cardiac remodeling and cardiac fibrosis. Immune-fibroblast ligand-receptor axes (e.g., IL-1β-IL-1R, SPP1-CD44, TGF-β-TGFβR, PDGF-PDGFRα/β, GAS6-MERTK) vs. Cancer-associated fibroblast (CAF) activation pathways was evaluated. Immune-fibroblast ligand-receptor axes such as IL-1β-IL-1R and SPP1-CD44 drive post-infarction cardiac fibrosis and share conserved signaling pathways with cancer-associated fibroblasts.
Synapse has enriched 10 related papers. Consider them for comparative context: